Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in Drug-Resistant Epilepsy
NCT03475225Phase 3Completed
- Sponsor
- Centre Hospitalier Sainte-Anne
- Start
- Apr 2018
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in epilepsy, sponsored by Centre Hospitalier Sainte-Anne. Started Apr 2018; status: completed.
02
Drugs
vitamin d
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03475225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03475225.